<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12</volume><submitter>Sajdel-Sulkowska EM</submitter><pubmed_abstract>SARS-CoV-2, primarily considered a respiratory virus, is increasingly recognized as having gastrointestinal aspects based on its presence in the gastrointestinal (GI) tract and feces. SARS-CoV-2 uses as a receptor angiotensin-converting enzyme 2 (ACE-2), a critical member of the renin-angiotensin-aldosterone system (RAAS) involved in the regulation of blood pressure and fluid system. In addition to the systemic endocrine functions, RAAS components are also involved in intracrine and organ-specific local functions. The angiotensin-converting enzyme 2 (ACE-2) is a key component of RAAS and a receptor for SARS-CoV-2. It is expressed in many tissues with gastrointestinal (GI) tract ACE-2 levels far exceeding those in the respiratory tract. SARS-CoV-2 binding to its receptor results in a defici</pubmed_abstract><journal>Frontiers in pharmacology</journal><pagination>684610</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8226136</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>A Dual-Route Perspective of SARS-CoV-2 Infection: Lung- vs. Gut-specific Effects of ACE-2 Deficiency.</pubmed_title><pmcid>PMC8226136</pmcid><pubmed_authors>Sajdel-Sulkowska EM</pubmed_authors></additional><is_claimable>false</is_claimable><name>A Dual-Route Perspective of SARS-CoV-2 Infection: Lung- vs. Gut-specific Effects of ACE-2 Deficiency.</name><description>SARS-CoV-2, primarily considered a respiratory virus, is increasingly recognized as having gastrointestinal aspects based on its presence in the gastrointestinal (GI) tract and feces. SARS-CoV-2 uses as a receptor angiotensin-converting enzyme 2 (ACE-2), a critical member of the renin-angiotensin-aldosterone system (RAAS) involved in the regulation of blood pressure and fluid system. In addition to the systemic endocrine functions, RAAS components are also involved in intracrine and organ-specific local functions. The angiotensin-converting enzyme 2 (ACE-2) is a key component of RAAS and a receptor for SARS-CoV-2. It is expressed in many tissues with gastrointestinal (GI) tract ACE-2 levels far exceeding those in the respiratory tract. SARS-CoV-2 binding to its receptor results in a defici</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021</publication><modification>2025-05-31T23:49:53.079Z</modification><creation>2025-05-31T23:49:53.079Z</creation></dates><accession>S-EPMC8226136</accession><cross_references><pubmed>34177593</pubmed><doi>10.3389/fphar.2021.684610</doi></cross_references></HashMap>